Genprex, Inc. Stock price
Is Genprex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Genprex, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a Genprex, Inc. forecast:
Analyst Opinions
7 Analysts have issued a Genprex, Inc. forecast:
Don't miss a Thing! We will send you all news about Genprex, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Genprex, Inc. Stock News
Company Profile
Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
| Head office | United States |
| CEO | Mr. Confer |
| Employees | 13 |
| Founded | 2009 |
| Website | www.genprex.com |


